Registry Search

8,240 Clinical Drug Overviews

Medication	Therapeutic Class	Generic Mapping	Safety
ELIXOMIN Comprehensive clinical and safety monograph for ELIXOMIN (ELIXOMIN).	Xanthine Bronchodilator	ELIXOMIN	caution
ELIXOPHYLLIN Comprehensive clinical and safety monograph for ELIXOPHYLLIN (ELIXOPHYLLIN).	Xanthine Bronchodilator	ELIXOPHYLLIN	caution
ELIXOPHYLLIN SR Comprehensive clinical and safety monograph for ELIXOPHYLLIN SR (ELIXOPHYLLIN SR).	Xanthine Bronchodilator	ELIXOPHYLLIN SR	caution
ELLA Comprehensive clinical and safety monograph for ELLA (ELLA).	Emergency Contraceptive	ELLA	caution
ELLENCE Comprehensive clinical and safety monograph for ELLENCE (ELLENCE).	Anthracycline Antineoplastic	ELLENCE	caution
ELLIOTTS B SOLUTION Comprehensive clinical and safety monograph for ELLIOTTS B SOLUTION (ELLIOTTS B SOLUTION).	Ophthalmic Irrigating Solution	ELLIOTTS B SOLUTION	caution
ELMIRON Comprehensive clinical and safety monograph for ELMIRON (ELMIRON).	Urinary Tract Agent	ELMIRON	caution
ELOCON Comprehensive clinical and safety monograph for ELOCON (ELOCON).	Topical Corticosteroid	ELOCON	caution
ELOXATIN Comprehensive clinical and safety monograph for ELOXATIN (ELOXATIN).	Platinum-Based Antineoplastic	ELOXATIN	caution
ELREXFIO Comprehensive clinical and safety monograph for ELREXFIO (ELREXFIO).	Bispecific Antibody Antineoplastic	ELREXFIO	caution
ELSPAR Comprehensive clinical and safety monograph for ELSPAR (ELSPAR).	Enzyme Antineoplastic	ELSPAR	caution
ELTROMBOPAG Comprehensive clinical and safety monograph for ELTROMBOPAG (ELTROMBOPAG).	Thrombopoietin Receptor Agonist	ELTROMBOPAG	caution
ELTROMBOPAG OLAMINE Comprehensive clinical and safety monograph for ELTROMBOPAG OLAMINE (ELTROMBOPAG OLAMINE).	Thrombopoietin Receptor Agonist	ELTROMBOPAG OLAMINE	caution
ELUCIREM Comprehensive clinical and safety monograph for ELUCIREM (ELUCIREM).	Gadolinium-Based Contrast Agent	ELUCIREM	caution
ELURYNG Comprehensive clinical and safety monograph for ELURYNG (ELURYNG).	Combination Contraceptive	ELURYNG	caution
ELUXADOLINE Comprehensive clinical and safety monograph for ELUXADOLINE (ELUXADOLINE).	Opioid Receptor Modulator	ELUXADOLINE	caution
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE	safe
ELYXYB Comprehensive clinical and safety monograph for ELYXYB (ELYXYB).	NSAID (COX-2 Inhibitor)	ELYXYB	caution
ELZONRIS Comprehensive clinical and safety monograph for ELZONRIS (ELZONRIS).	CD123-Directed Cytotoxin	ELZONRIS	caution
EMADINE Comprehensive clinical and safety monograph for EMADINE (EMADINE).	Ophthalmic Antihistamine	EMADINE	caution
EMBEDA Comprehensive clinical and safety monograph for EMBEDA (EMBEDA).	Opioid Analgesic	EMBEDA	caution
EMBELINE Comprehensive clinical and safety monograph for EMBELINE (EMBELINE).	Emollient	EMBELINE	caution
EMBELINE E Comprehensive clinical and safety monograph for EMBELINE E (EMBELINE E).	Emollient	EMBELINE E	caution
EMBLAVEO Comprehensive clinical and safety monograph for EMBLAVEO (EMBLAVEO).	Anticoagulant	EMBLAVEO	caution
EMBOLEX Comprehensive clinical and safety monograph for EMBOLEX (EMBOLEX).	Low Molecular Weight Heparin	EMBOLEX	caution
EMCYT Comprehensive clinical and safety monograph for EMCYT (EMCYT).	Alkylating Agent	EMCYT	caution
EMEND Comprehensive clinical and safety monograph for EMEND (EMEND).	Antiemetic	EMEND	caution
EMERPHED Comprehensive clinical and safety monograph for EMERPHED (EMERPHED).	Sympathomimetic	EMERPHED	caution
EMETE-CON Comprehensive clinical and safety monograph for EMETE-CON (EMETE-CON).	Antiemetic	EMETE-CON	caution
EMFLAZA Comprehensive clinical and safety monograph for EMFLAZA (EMFLAZA).	Corticosteroid	EMFLAZA	caution
EMGALITY Comprehensive clinical and safety monograph for EMGALITY (EMGALITY).	CGRP Monoclonal Antibody	EMGALITY	caution
EMGEL Comprehensive clinical and safety monograph for EMGEL (EMGEL).	Topical Antibiotic	EMGEL	caution
EMLA Comprehensive clinical and safety monograph for EMLA (EMLA).	Local Anesthetic	EMLA	caution
EMOQUETTE Comprehensive clinical and safety monograph for EMOQUETTE (EMOQUETTE).	Combination Oral Contraceptive	EMOQUETTE	caution
EMPAGLIFLOZIN Diuretics may enhance the potential for volume depletion Can cause genital mycotic infections and volume depletion.	SGLT2 Inhibitor	EMPAGLIFLOZIN	caution
EMPAGLIFLOZIN AND LINAGLIPTIN No significant drug interactions May cause hypersensitivity reactions including anaphylaxis.	DPP-4 Inhibitor	EMPAGLIFLOZIN AND LINAGLIPTIN	safe
EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE Alcohol and contrast dye can increase risk of lactic acidosis Can cause lactic acidosis a rare but serious metabolic complication.	Biguanide	EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE	safe
EMPAGLIFLOZIN; LINAGLIPTIN No significant drug interactions May cause hypersensitivity reactions including anaphylaxis.	DPP-4 Inhibitor	EMPAGLIFLOZIN; LINAGLIPTIN	safe
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE Alcohol and contrast dye can increase risk of lactic acidosis Can cause lactic acidosis a rare but serious metabolic complication.	Biguanide	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	safe
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE Alcohol and contrast dye can increase risk of lactic acidosis Can cause lactic acidosis a rare but serious metabolic complication.	Biguanide	EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE	safe
EMPAVELI Comprehensive clinical and safety monograph for EMPAVELI (EMPAVELI).	Complement Inhibitor	EMPAVELI	caution
EMPLICITI Comprehensive clinical and safety monograph for EMPLICITI (EMPLICITI).	Monoclonal Antibody Antineoplastic	EMPLICITI	caution
EMPRACET W/ CODEINE PHOSPHATE #3 CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur especially in CYP2D6 ultra-rapid metabolizers.	Opioid Agonist	EMPRACET W/ CODEINE PHOSPHATE #3	avoid
EMPRACET W/ CODEINE PHOSPHATE #4 CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur especially in CYP2D6 ultra-rapid metabolizers.	Opioid Agonist	EMPRACET W/ CODEINE PHOSPHATE #4	avoid
EMRELIS Comprehensive clinical and safety monograph for EMRELIS (EMRELIS).	Antiemetic	EMRELIS	caution
EMROSI Comprehensive clinical and safety monograph for EMROSI (EMROSI).	Topical Antibiotic	EMROSI	caution
EMSAM Comprehensive clinical and safety monograph for EMSAM (EMSAM).	Monoamine Oxidase Inhibitor Antidepressant	EMSAM	caution
EMTRICITABINE Comprehensive clinical and safety monograph for EMTRICITABINE (EMTRICITABINE).	Antiretroviral, NRTI	EMTRICITABINE	caution
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EMTRICITABINE AND TENOFOVIR ALAFENAMIDE	safe
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE	safe

Showing 2401 - 2450 of 8245

Previous Next